Cargando…
Prime editor‐mediated functional reshaping of ACE2 prevents the entry of multiple human coronaviruses, including SARS‐CoV‐2 variants
The spike protein of SARS‐CoV‐2 hijacks the host angiotensin converting enzyme 2 (ACE2) to meditate its entry and is the primary target for vaccine development. Nevertheless, SARS‐CoV‐2 keeps evolving and the latest Omicron subvariants BQ.1 and XBB have gained exceptional immune evasion potential th...
Autores principales: | Zhao, Wenwen, Li, Jifang, Wang, Xiao, Xu, Wei, Gao, Bao‐Qing, Xiang, Jiangchao, Hou, Yaofeng, Liu, Wei, Wu, Jing, Qi, Qilian, Wei, Jia, Yang, Xiaoyu, Lu, Lu, Yang, Li, Chen, Jia, Yang, Bei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10492923/ https://www.ncbi.nlm.nih.gov/pubmed/37701533 http://dx.doi.org/10.1002/mco2.356 |
Ejemplares similares
-
Colonic expression of Ace2, the SARS-CoV-2 entry receptor, is suppressed by commensal human microbiota
por: Edwinson, Adam, et al.
Publicado: (2021) -
Glycyrrhizin Inhibits SARS-CoV-2 Entry into Cells by Targeting ACE2
por: He, Ming-Feng, et al.
Publicado: (2022) -
ACE2-Independent Bat Sarbecovirus Entry and Replication in Human and Bat Cells
por: Guo, Hua, et al.
Publicado: (2022) -
Antigenic mapping reveals sites of vulnerability on α-HCoV spike protein
por: Xiang, Jiangchao, et al.
Publicado: (2022) -
Fish ACE2 is not susceptible to SARS-CoV-2
por: Xie, Shi-Zhe, et al.
Publicado: (2022)